STAAR Surgical Company STAA
NASDAQ
| 10/02/2026 | 07/03/2026 | 04/03/2026 | 01/02/2026 | 09/26/2025 | |
|---|---|---|---|---|---|
| Net Income | 5.58M | 8.06M | 5.21M | -18.31M | 8.88M |
| Total Depreciation and Amortization | 2.43M | 2.39M | 2.11M | 2.01M | 2.00M |
| Total Amortization of Deferred Charges | 948.00K | 949.00K | 104.00K | 409.00K | 104.00K |
| Total Other Non-Cash Items | 2.83M | 10.98M | 13.58M | 11.06M | 22.57M |
| Change in Net Operating Assets | 15.53M | -2.68M | -42.69M | 924.00K | -30.89M |
| Cash from Operations | 27.32M | 19.69M | -21.70M | -3.91M | 2.67M |
| Capital Expenditure | -935.00K | -494.00K | -443.00K | -1.68M | -883.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -39.73M | -872.00K | 2.59M | -17.74M | 6.17M |
| Cash from Investing | -40.67M | -1.37M | 2.15M | -19.42M | 5.28M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 4.00K | 1.24M | 174.00K | 114.00K | 2.97M |
| Repurchase of Common Stock | -1.32M | -2.74M | -1.87M | -164.00K | -1.98M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.32M | -1.50M | -1.69M | -50.00K | 983.00K |
| Foreign Exchange rate Adjustments | -297.00K | -107.00K | -45.00K | 374.00K | 91.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.97M | 16.72M | -21.29M | -23.01M | 9.02M |